(Q34059366)

30 July 2017

1 reference

title

Immune tolerance therapy for haemophilia (English)

1 reference

30 July 2017

0 references

Ho AY

1

1 reference

30 July 2017

Height SE

series ordinal

2

1 reference

30 July 2017

Smith MP

series ordinal

3

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

60

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

547-554

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200060030-00003

30 July 2017

exact match

0 references

cites work

Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII.

1 reference

12 December 2020

HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII

1 reference

12 December 2020

Genetic predisposition to inhibitor formation

1 reference

12 December 2020

Factor VIII gene inversions in severe hemophilia A: results of an international consortium study.

1 reference

12 December 2020

Autoimmune factor VIII inhibitors

1 reference

12 December 2020

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

1 reference

12 December 2020

Absence of inhibitors in previously untreated patients with severe haemophilia A after exposure to a single intermediate purity factor VIII product

1 reference

12 December 2020

Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene

1 reference

12 December 2020

The sequence Glu1811-Lys1818 of human blood coagulation factor VIII comprises a binding site for activated factor IX.

1 reference

12 December 2020

Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapy

1 reference

12 December 2020

Pharmaco-economic aspects of inhibitor treatment.

1 reference

12 December 2020

Immune tolerance in hemophilia-principal results from the International Registry. Report of the factor VIII and IX Subcommittee.

1 reference

12 December 2020

Peripheral deletion of antigen-reactive T cells in oral tolerance.

1 reference

12 December 2020

Immune tolerance therapy for haemophilia A patients with acquired factor VIII alloantibodies: comprehensive analysis of experience at a single institution

1 reference

12 December 2020

Protocols, dosages and clinical aspects of immune tolerance

1 reference

12 December 2020

Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom

1 reference

12 December 2020

Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey.

1 reference

12 December 2020

Induction of immune tolerance in a 7-year-old hemophiliac with an anaphylactoid inhibitor

1 reference

12 December 2020

Factor VIII inhibitors in previously treated haemophilia A patients with a double virus-inactivated plasma derived factor VIII concentrate

1 reference

12 December 2020

Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens

1 reference

12 December 2020

Low-dose immune tolerance therapy: the van creveld model.

1 reference

12 December 2020

Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII.

1 reference

12 December 2020

Immune tolerance for the treatment of factor VIII inhibitors--twenty years' 'bonn protocol'.

1 reference

12 December 2020

Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols

1 reference

12 December 2020

Molecular basis of factor VIII inhibition by human antibodies. Antibodies that bind to the factor VIII light chain prevent the interaction of factor VIII with phospholipid

1 reference

12 December 2020

Low-dose immune tolerance induction in hemophilia A patients with inhibitors

1 reference

12 December 2020

Haemophilia A: database of nucleotide substitutions, deletions, insertions and rearrangements of the factor VIII gene, second edition

1 reference

12 December 2020

The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.

1 reference

12 December 2020

Prevalence of inhibitors in a population of 3435 hemophilia patients in France. French Hemophilia Study Group

1 reference

12 December 2020

Characterization of factor VIII B-cell inhibitory epitopes.

1 reference

12 December 2020

Haemophilia A: mutation type determines risk of inhibitor formation

1 reference

12 December 2020

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

1 reference

12 December 2020

Anti-idiotypic suppression of antibodies to factor VIIIc

1 reference

12 December 2020

Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody

1 reference

12 December 2020

Immune tolerance to Factor VIII: the international registry data

1 reference

12 December 2020

Human anti-factor VIII antibodies: epitope localization and inhibitory function

1 reference

12 December 2020

Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group

1 reference

12 December 2020

The role of genetics in inhibitor formation

1 reference

12 December 2020

Frequent but low titre factor VIII inhibitors in haemophilia A patients treated with high purity concentrates.

1 reference

12 December 2020

Induction of immune tolerance to factor VIII: a plea for caution

1 reference

12 December 2020

Proceedings: A more uniform measurement of factor VIII inhibitors

1 reference

12 December 2020

The treatment of factor VIII inhibitors--a general overview

1 reference

12 December 2020

French previously untreated patients with severe hemophilia A after exposure to recombinant factor VIII : incidence of inhibitor and evaluation of immune tolerance

1 reference

12 December 2020

Development of a factor VIII inhibitor in a newborn haemophiliac

1 reference

12 December 2020

Factor VIII inhibitors in mild and moderate-severity haemophilia A.

1 reference

12 December 2020

Immune tolerance and the immune modulation protocol

1 reference

12 December 2020

The management of hemophilia patients with inhibitors

1 reference

12 December 2020

Screening for inversions in the factor VIII (F8) gene causing severe haemophilia A.

1 reference

12 December 2020

How do some haemophiliacs develop inhibitors?

1 reference

12 December 2020

Immunoadsorption for removal of inhibitors: update on treatments in Malmö-Lund between 1980 and 1995.

1 reference

12 December 2020

Choices following antigen entry: antibody formation or immunologic tolerance?

1 reference

12 December 2020

Massive factor-VIII infusion in haemophiliac with factor-VIII inhibitor, high responder

1 reference

12 December 2020

CD4+ T cell response to factor VIII in hemophilia A, acquired hemophilia, and healthy subjects.

1 reference

12 December 2020

Treatment of acute bleeds with recombinant activated factor VII during immune tolerance therapy

1 reference

12 December 2020

Induction of tolerance using porcine factor VIII.

1 reference

12 December 2020

High incidence of anti-FVIII antibodies against non-coagulant epitopes in haemophilia A patients: a possible role for the half-life of transfused FVIII.

1 reference

12 December 2020

Control of isotype switching by T cells and cytokines

1 reference

12 December 2020

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

1 reference

12 December 2020

Management of haemophilia B patients with inhibitors and anaphylaxis

1 reference

12 December 2020

Nephrotic syndrome as a complication of immune tolerance in hemophilia B.

1 reference

12 December 2020

Rising Factor VIII Inhibitor Titers after Konȳne Factor IX Complex

1 reference

12 December 2020

The economics of immune tolerance and treatment of hemophiliacs with inhibitors

1 reference

12 December 2020

Inhibition of human factor VIIIa by anti-A2 subunit antibodies

1 reference

12 December 2020

Recommendations for the treatment of factor VIII inhibitors: from the UK Haemophilia Centre Directors' Organisation Inhibitor Working Party

1 reference

12 December 2020

10.2165/00003495-200060030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1033918824

0 references

Fatcat ID

release_qry4mxc7ybby3hh3ffe5cgs2aq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qry4mxc7ybby3hh3ffe5cgs2aq

24 November 2022

mapped directly with Wikidata item

1 reference